INSP
Price
$128.50
Change
-$1.22 (-0.94%)
Updated
Jun 27, 10:41 AM (EDT)
Capitalization
6.35B
39 days until earnings call
MASI
Price
$166.71
Change
-$2.59 (-1.53%)
Updated
Jun 26 closing price
Capitalization
7.66B
46 days until earnings call
Interact to see
Advertisement

INSP vs MASI

Header iconINSP vs MASI Comparison
Open Charts INSP vs MASIBanner chart's image
Inspire Medical Systems
Price$128.50
Change-$1.22 (-0.94%)
Volume$300
Capitalization6.35B
Masimo
Price$166.71
Change-$2.59 (-1.53%)
Volume$590.11K
Capitalization7.66B
INSP vs MASI Comparison Chart in %
Loading...
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INSP vs. MASI commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INSP is a StrongBuy and MASI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (INSP: $129.71 vs. MASI: $166.71)
Brand notoriety: INSP and MASI are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INSP: 70% vs. MASI: 95%
Market capitalization -- INSP: $6.35B vs. MASI: $7.66B
INSP [@Medical Specialties] is valued at $6.35B. MASI’s [@Medical Specialties] market capitalization is $7.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INSP’s FA Score shows that 0 FA rating(s) are green whileMASI’s FA Score has 1 green FA rating(s).

  • INSP’s FA Score: 0 green, 5 red.
  • MASI’s FA Score: 1 green, 4 red.
According to our system of comparison, MASI is a better buy in the long-term than INSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INSP’s TA Score shows that 5 TA indicator(s) are bullish while MASI’s TA Score has 6 bullish TA indicator(s).

  • INSP’s TA Score: 5 bullish, 2 bearish.
  • MASI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, INSP is a better buy in the short-term than MASI.

Price Growth

INSP (@Medical Specialties) experienced а +0.01% price change this week, while MASI (@Medical Specialties) price change was +2.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.72%. For the same industry, the average monthly price growth was +1.04%, and the average quarterly price growth was -0.32%.

Reported Earning Dates

INSP is expected to report earnings on Aug 05, 2025.

MASI is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.72% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MASI($7.66B) has a higher market cap than INSP($6.35B). MASI YTD gains are higher at: 0.853 vs. INSP (-30.030). MASI has higher annual earnings (EBITDA): 237M vs. INSP (-17.06M). INSP has more cash in the bank: 460M vs. MASI (163M). INSP has less debt than MASI: INSP (24.8M) vs MASI (970M). MASI has higher revenues than INSP: MASI (2.05B) vs INSP (625M).
INSPMASIINSP / MASI
Capitalization6.35B7.66B83%
EBITDA-17.06M237M-7%
Gain YTD-30.0300.853-3,521%
P/E RatioN/A95.93-
Revenue625M2.05B31%
Total Cash460M163M282%
Total Debt24.8M970M3%
FUNDAMENTALS RATINGS
INSP vs MASI: Fundamental Ratings
INSP
MASI
OUTLOOK RATING
1..100
366
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
79100
SMR RATING
1..100
6597
PRICE GROWTH RATING
1..100
8346
P/E GROWTH RATING
1..100
10016
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INSP's Valuation (76) in the Medical Specialties industry is in the same range as MASI (90). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.

INSP's Profit vs Risk Rating (79) in the Medical Specialties industry is in the same range as MASI (100). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.

INSP's SMR Rating (65) in the Medical Specialties industry is in the same range as MASI (97). This means that INSP’s stock grew similarly to MASI’s over the last 12 months.

MASI's Price Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for INSP (83). This means that MASI’s stock grew somewhat faster than INSP’s over the last 12 months.

MASI's P/E Growth Rating (16) in the Medical Specialties industry is significantly better than the same rating for INSP (100). This means that MASI’s stock grew significantly faster than INSP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INSPMASI
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
68%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 8 days ago
86%
Bullish Trend 5 days ago
70%
Declines
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
67%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
62%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
INSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MASI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FNGO107.453.50
+3.37%
MicroSectors™ FANG+™ 2X Leveraged ETN
IGTR24.430.31
+1.30%
Innovator Gradient Tactical Rot Str ETF
VTI301.942.58
+0.86%
Vanguard Total Stock Market ETF
FXZ57.200.43
+0.76%
First Trust Materials AlphaDEX® ETF
FALN26.990.09
+0.33%
iShares Fallen Angels USD Bond ETF

MASI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MASI has been loosely correlated with ISRG. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if MASI jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MASI
1D Price
Change %
MASI100%
-1.53%
ISRG - MASI
48%
Loosely correlated
+2.41%
INSP - MASI
46%
Loosely correlated
-1.73%
BSX - MASI
44%
Loosely correlated
+0.28%
VCYT - MASI
44%
Loosely correlated
+1.36%
ALGN - MASI
42%
Loosely correlated
+0.62%
More